Immunovant, Inc.IMVTNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+14.6%
5Y CAGR+48.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+14.6%/yr
vs +721.6%/yr prior
5Y CAGR
+48.0%/yr
Recent deceleration
Acceleration
-706.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$776.22M+16.4%
2024$666.71M+64.3%
2023$405.84M-21.3%
2022$515.56M+25.0%
2021$412.49M+277.1%
2020$109.39M+26909.1%
2019$405000.00+257.9%
2018$113170.00-